RITUXAN Safety Questions, RITUXAN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about RITUXAN. Our extensive database of RITUXAN adverse events and RITUXAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about RITUXAN
RITUXAN Safety Reports
Total RITUXAN reports: 848.RITUXAN FDA safety alerts: 2004 2006 .
Reported deaths: 139 Reported hospitalizations: 371.
Take RITUXAN Side Effects Survey or Share Your RITUXAN Story. RITUXAN Usage.
Showing 1-75 of 848 Next >
Health Professional from JAPAN reported RITUXAN problem on Feb 23, 2007. Male patient, 69 years of age, weighting 154.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastric cancer, lymphadenopathy, no therapeutic response. RITUXAN dosage: 375 MG, UNK, INTRAVENOUS. During the same period patient was treated with ZEVALIN, CLADRIBINE, CYCLOPHOSPHAMIDE, PREDNISOLONE, PROCARBAZINE. Patient was hospitalized. Patient recovered.RITUXAN problem was reported by a Pharmacist from UNITED STATES on Mar 09, 2007. Female patient, weighting 244.7 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: chills, dyspnoea, infusion related reaction, muscle spasms, pain in extremity, pyrexia. RITUXAN dosage: 800 MG X1 IV DRIP. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Feb 23, 2007. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: 640 MG, QD INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, METHYLCOBALAMIN, HYTRIL, LAFUTIDINE. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, helicobacter infection. RITUXAN dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Mar 02, 2007. Female patient, 39 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, chills, culture urine positive, knee arthroplasty, nephrolithiasis, pyrexia. RITUXAN dosage: 1000 MG, X2, INTRAVENOUS. During the same period patient was treated with LEVAQUIN. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from UNITED STATES on Feb 26, 2007. Female patient, 72 years of age, weighting 226.4 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood glucose increased, coronary artery occlusion. RITUXAN dosage: 1000 MG, DAYS 1+5, INTRAVENOUS. During the same period patient was treated with ALTACE, TOPROL, NORVASC, METHOTREXATE, FOLATE, GLIPIZIDE, METFORMIN, LIPITOR. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Mar 01, 2007. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, lung infiltration, pleural effusion, pulmonary toxicity. RITUXAN dosage: 630 MG Q3W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Health Professional from JAPAN on Feb 27, 2007. Male patient, 65 years of age, weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, gastric cancer, gastritis erosive, immune system disorder, lymphocyte count decreased. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, BIOFERMIN, METHYLCOBAL, RILMAZAFONE HYDROCHLORIDE, AMLODIPINE BESYLATE, SENNA LEAF, SUCRALFATE, ETIZOLAM. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported RITUXAN problem on Feb 27, 2007. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pancreatitis. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient recovered.
RITUXAN problem was reported by a Physician from CANADA on Feb 27, 2007. Female patient was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Feb 27, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, hemiplegia. RITUXAN dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 71 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, blood pressure decreased, bronchopulmonary aspergillosis, culture urine positive, cytomegalovirus infection, cytomegalovirus urinary tract infection, enterococcal infection, herpes zoster. RITUXAN dosage: 532 MG, QD; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died on 12/01/2006.
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 01, 2007. Male patient, 87 years of age, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, infusion site reaction, loss of consciousness, pulse absent, transient ischaemic attack, urinary incontinence, white blood cell count increased. RITUXAN dosage: 600 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with DECADRON, TYLENOL, BENADRYL. Patient recovered.
RITUXAN problem was reported by a Health Professional from UNITED STATES on Feb 27, 2007. Male patient was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased. RITUXAN dosage: unknown. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient was diagnosed with sjogren's syndrome and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis. RITUXAN dosage: 100 MG,X2, INTRAVENOUS. Patient recovered.
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, 28 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abortion induced, platelet count decreased, pregnancy. RITUXAN dosage: 600 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with IMMUNE GLOBULIN, PREDNISOLOLNE. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Feb 28, 2007. Female patient, 69 years of age, weighting 83.78 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: asthma, vomiting. RITUXAN dosage: 480 MG, INTRAVENOUS. During the same period patient was treated with ENDOAN, DOXORUBICIN, ONCOVIN, PREDONINE, ADALAT, LISINOPRIL, FAMOTIDINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Mar 01, 2007. Female patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, anorexia, asthenia, autonomic nervous system imbalance, blood potassium increased, blood pressure decreased, dehydration, diplopia, electrolyte imbalance. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ALFAROL, MAGNESIUM OXIDE, ISONIAZID, ITRIZOLE, ZOLPIDEM TARTRATE, SULFAMETHOXAZOLE, POLAPREZINC. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported RITUXAN problem on Mar 02, 2007. Female patient, 41 years of age, weighting 123.5 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood chloride decreased, blood lactate dehydrogenase increased, neutrophil count increased, platelet count increased, viral myocarditis, white blood cell count increased. RITUXAN dosage: 1000 MG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, PREDNISONE, METHOTREXATE, NAPROXEN, FOLIC ACID, TYLENOL #, LORTAB. Patient died on 09/21/2006.
RITUXAN problem was reported by a Physician from UNITED STATES on Mar 02, 2007. Male patient, 60 years of age, weighting 252.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: dehydration, fatigue, pyrexia. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Male patient, 63 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anaemia, lung disorder, no therapeutic response, t-cell lymphoma. RITUXAN dosage: 375 MG/M2. During the same period patient was treated with PENTOSTATIN, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, DIPHENHYDRAMINE, HYDROCORTISONE, MEPERIDINE, ONDANSETRON, PROMETHEZINE. Patient recovered.
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2007. Male patient, 80 years of age, was diagnosed with neoplasm malignant and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anorexia, dizziness, dry mouth, fatigue, neoplasm progression. RITUXAN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient, 59 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, polyarthritis. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2007. Male patient, 54 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arthritis. RITUXAN dosage: unknown. During the same period patient was treated with PREDNISONE, IMURAN, ASPIRIN, PRILOSEC, TYLENOL, CODEINE SUL. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, condition aggravated, rheumatoid arthritis. RITUXAN dosage: 100 MG, SINGLE, INTRAVENOUS. Patient recovered.
RITUXAN problem was reported by a Physician from UNITED STATES on Mar 10, 2007. Female patient, 43 years of age, weighting 142.0 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: complication of pregnancy. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with EFFEXOR, XANAX, GABAPENTIN. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Feb 28, 2007. Male patient, 71 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. RITUXAN dosage: unknown. During the same period patient was treated with STEROID, GLOBULIN NOS. Patient died.
RITUXAN problem was reported by a Physician from JAPAN on Mar 10, 2007. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: femoral neck fracture, lumbar vertebral fracture, red blood cell count decreased, white blood cell count decreased. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, ETOPOSIDE. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Mar 10, 2007. Male patient, 79 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, jaundice, liver disorder, pyrexia. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PIRARUBICIN, VINDESINE, PREDNISOLONE, URSODESOXYCHOLIC ACID, PANTETHINE, MAGNESIUM OXIDE, TRICHLORMETHIAZIDE. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastric cancer. RITUXAN dosage: unknown. During the same period patient was treated with ETOPOSIDE, METHYLPREDNISOLONE, CYTARABINE, CISPLATIN. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Mar 06, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Mar 01, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, depressed level of consciousness, hepatitis b, urine output decreased. RITUXAN dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, CLARITIN, IBUPROFEN, REASTAMIN, VOLTAREN. Patient died on 01/09/2007.
Physician from JAPAN reported RITUXAN problem on Mar 01, 2007. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, obstruction gastric, pancreatic disorder. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Female patient, 78 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abnormal faeces, chest discomfort, fatigue, international normalised ratio increased, platelet count decreased. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported RITUXAN problem on Mar 10, 2007. Female patient, 27 years of age, was diagnosed with central nervous system lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: bradycardia. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with TEMODAR. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma recurrent, bile duct cancer. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Mar 04, 2007. Male patient, 68 years of age, weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anaemia, gastric ulcer, gastrointestinal haemorrhage, helicobacter infection, hepatic failure, tumour lysis syndrome. RITUXAN dosage: 375 MG, QD, INTRAVENOUS. During the same period patient was treated with FERROMIA, LASIX, ALDACTONE, URSO, OCTOTIAMINE, ASPARA, CHINESE MEDICINE, MOSAPRIDE CITRATE. Patient recovered.
RITUXAN problem was reported by a Physician from NORWAY on Mar 07, 2007. Female patient, 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHASPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
Physician from UNITED KINGDOM reported RITUXAN problem on Mar 14, 2007. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: atelectasis, c-reactive protein increased, chest pain, haemoglobin decreased, hypoxia, lymphocyte count decreased, neutrophil count decreased, pericardial rub, pleuritic pain. RITUXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, FOLIC ACID, ALENDRONATE, CALCICHEW DE, AMITRIPRYLINE, KETOPROFEN. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from NORWAY on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: opportunistic infection, pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE. Patient recovered.
Health Professional from NORWAY reported RITUXAN problem on Mar 07, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
RITUXAN problem was reported by a Health Professional from NORWAY on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
Pharmacist from JAPAN reported RITUXAN problem on Mar 07, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
RITUXAN problem was reported by a Health Professional from NORWAY on Mar 07, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISONE. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Mar 06, 2007. Female patient, 84 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: aplasia, bone marrow failure. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PANTOPRAZOLE, AMLODIPINE BESYLATE, CLONAZEPAM, ACYCLOVIR. Patient recovered.
RITUXAN problem was reported by a Physician from UNITED STATES on Mar 09, 2007. Female patient, 65 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. RITUXAN dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 08, 2007. Female patient, 67 years of age, weighting 134.9 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gallbladder operation. RITUXAN dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 59 years of age, weighting 131.0 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: air-borne transmission. RITUXAN dosage: unknown. During the same period patient was treated with PREMPRO, OXYCONTIN, FOLIC ACID, OXYCODONE, WELLBUTRIN, EFFEXOR, CYMBALTA, NEURONTIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported RITUXAN problem on Mar 09, 2007. Female patient, 72 years of age, weighting 226.4 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood glucose increased, coronary artery occlusion. RITUXAN dosage: 1000 MG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with ALTACE, TOPROL, NORVASC, METHOTREXATE, FOLATE, GLIPIZIDE, METFORMIN, LIPITOR. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from NORWAY on Mar 07, 2007. Female patient, 58 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE. Patient recovered.
Physician from GERMANY reported RITUXAN problem on Mar 13, 2007. Male patient, child 2 years of age, weighting 4.41 lb, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: herpes sepsis, herpes zoster, hypogammaglobulinaemia, intestinal functional disorder, lung disorder, meningeal disorder, pneumonia parainfluenzae viral. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISOLONE, DAPSONE. Patient recovered.
RITUXAN problem was reported by a Health Professional from GERMANY on Mar 13, 2007. Female patient, 81 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: pneumonia bacterial, pulmonary embolism. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. Patient recovered.
Health Professional from GERMANY reported RITUXAN problem on Mar 13, 2007. Female patient, 63 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: gastroenteritis clostridial, intestinal functional disorder, pneumonia. RITUXAN dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient recovered.
RITUXAN problem was reported by a Pharmacist from UNITED STATES on Mar 23, 2007. Female patient, weighting 118.6 lb, was diagnosed with graft thrombosis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, air embolism, arteriosclerosis coronary artery, chest pain, infusion related reaction, pericardial effusion, pleural effusion, sepsis syndrome, shock. RITUXAN dosage: 33.3 MG ONCE IV DRIP. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from GERMANY reported RITUXAN problem on Mar 13, 2007. Female patient, 63 years of age, was diagnosed with pemphigoid and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: clostridial infection, pneumonia bacterial. RITUXAN dosage: 375 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient died.
RITUXAN problem was reported by a Physician from UNITED STATES on Mar 14, 2007. Female patient, 55 years of age, was diagnosed with dermatomyositis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arrhythmia. RITUXAN dosage: 1000 MG, INTRAVENOUS. Patient died on 03/10/2007.
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on Mar 14, 2007. Male patient, 67 years of age, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, ejection fraction decreased, fluid retention, palpitations, weight increased. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE, DEXAMETHASONE, CYTARABINE, LEUCOVORIN CALCIUM, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.
RITUXAN problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, 60 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cholelithiasis. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with FOLIC ACID, METHOTREXATE, PRILOSEC, ZYRTEC, ACTONEL, LORTAB, ULTRAM, CELEBREX. Patient was hospitalized. Patient recovered.
Physician from CANADA reported RITUXAN problem on Mar 14, 2007. Female patient was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, lung disorder. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Mar 15, 2007. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: prepyloric stenosis. RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE. Patient recovered.
Physician from CANADA reported RITUXAN problem on Mar 19, 2007. Female patient, 59 years of age, weighting 143.3 lb, was diagnosed with lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cellulitis, neutropenia. RITUXAN dosage: 375 MG/M2, UNK; INTRAVENOUS. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Female patient, 71 years of age, weighting 162.0 lb, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, surgery. RITUXAN dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Mar 23, 2007. Female patient, 40 years of age, was diagnosed with systemic lupus erythematosus and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: systemic lupus erythematosus. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, DURAGESIC, FOSAMAX, ZOFRAN, NORTRIPTYLIN. Patient recovered.
RITUXAN problem was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. RITUXAN dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with LISINOPRIL, PROTONIX, PREDNISONE. Patient was hospitalized. Patient recovered.
Physician from CANADA reported RITUXAN problem on Mar 20, 2007. Male patient, 84 years of age, weighting 134.5 lb, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: anuria, chills, hypotension. RITUXAN dosage: 640 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Mar 23, 2007. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: peritonitis. RITUXAN dosage: 570 MG, SINGLE; INTRAVENOUS, 560 MG, SINGLE; INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, PARAPLATIN, ETOPOSIDE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Mar 19, 2007. Female patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, diffuse large b-cell lymphoma recurrent. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Health Professional from RUSSIAN FEDERATION on Mar 23, 2007. Male patient, 72 years of age, weighting 181.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cavernous sinus thrombosis, sinusitis. RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, AMOXICLAV. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported RITUXAN problem on Dec 27, 2006. Female patient, 28 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: caesarean section, pre-eclampsia. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Dec 27, 2006. Female patient, 72 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: arthralgia, gait disturbance, joint swelling, osteonecrosis. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADIRACIN, ONCOVIN, PREDNISOLONE, VEPESID. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Feb 28, 2007. Male patient, 71 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. RITUXAN dosage: unknown. During the same period patient was treated with STEROID, GLOBULIN NOS. Patient died.
RITUXAN problem was reported by a Physician from JAPAN on Mar 10, 2007. Male patient, 56 years of age, weighting 105.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: femoral neck fracture, lumbar vertebral fracture, red blood cell count decreased, white blood cell count decreased. RITUXAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE, ETOPOSIDE. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Mar 10, 2007. Male patient, 79 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, jaundice, liver disorder, pyrexia. RITUXAN dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PIRARUBICIN, VINDESINE, PREDNISOLONE, URSODESOXYCHOLIC ACID, PANTETHINE, MAGNESIUM OXIDE, TRICHLORMETHIAZIDE. Patient was hospitalized. Patient recovered.
RITUXAN problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: oesophageal carcinoma. RITUXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.
Physician from JAPAN reported RITUXAN problem on Mar 01, 2007. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, depressed level of consciousness, hepatitis b, urine output decreased. RITUXAN dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE, CLARITIN, IBUPROFEN, REASTAMIN, VOLTAREN. Patient died on 01/09/2007.
Showing 1-75 of 848 Next >
This
drug has an active FDA Safety Alert